DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys

Kerrie Vaughan, Gary H. Rhodes, Laurel J Gershwin

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

A DNA vaccine was tested in infant Rhesus macaques to evaluate its safety, immunogenicity and protective efficacy. Monkeys were vaccinated and challenged with a clinical isolate of human RSV. Vaccinated animals developed humoral and cellular responses following inoculation with plasmid DNA encoding the fusion (F) and nucleoprotein (N), from closely related bovine RSV. Vaccinated monkeys had decreased RSV in their lungs post-infection, and there was a qualitative difference in histopathology observed between vaccinated and unvaccinated animals. The combined result of safety and immunogenicity in a neonatal primate model is encouraging, suggesting the feasibility of DNA vaccines against RSV in infants.

Original languageEnglish (US)
Pages (from-to)2928-2942
Number of pages15
JournalVaccine
Volume23
Issue number22
DOIs
StatePublished - Apr 22 2005

Fingerprint

DNA Vaccines
Respiratory Syncytial Viruses
recombinant vaccines
Macaca mulatta
Haplorhini
monkeys
Immunization
immunization
Bovine respiratory syncytial virus
Human respiratory syncytial virus
immune response
Safety
viruses
nucleoproteins
Nucleoproteins
DNA
histopathology
Primates
animals
plasmids

Keywords

  • DNA immunization
  • Rhesus monkeys
  • RSV

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys. / Vaughan, Kerrie; Rhodes, Gary H.; Gershwin, Laurel J.

In: Vaccine, Vol. 23, No. 22, 22.04.2005, p. 2928-2942.

Research output: Contribution to journalArticle

Vaughan, Kerrie ; Rhodes, Gary H. ; Gershwin, Laurel J. / DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys. In: Vaccine. 2005 ; Vol. 23, No. 22. pp. 2928-2942.
@article{dfdd229e8bc8463eabd8e7379b18bf74,
title = "DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys",
abstract = "A DNA vaccine was tested in infant Rhesus macaques to evaluate its safety, immunogenicity and protective efficacy. Monkeys were vaccinated and challenged with a clinical isolate of human RSV. Vaccinated animals developed humoral and cellular responses following inoculation with plasmid DNA encoding the fusion (F) and nucleoprotein (N), from closely related bovine RSV. Vaccinated monkeys had decreased RSV in their lungs post-infection, and there was a qualitative difference in histopathology observed between vaccinated and unvaccinated animals. The combined result of safety and immunogenicity in a neonatal primate model is encouraging, suggesting the feasibility of DNA vaccines against RSV in infants.",
keywords = "DNA immunization, Rhesus monkeys, RSV",
author = "Kerrie Vaughan and Rhodes, {Gary H.} and Gershwin, {Laurel J}",
year = "2005",
month = "4",
day = "22",
doi = "10.1016/j.vaccine.2004.10.046",
language = "English (US)",
volume = "23",
pages = "2928--2942",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "22",

}

TY - JOUR

T1 - DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys

AU - Vaughan, Kerrie

AU - Rhodes, Gary H.

AU - Gershwin, Laurel J

PY - 2005/4/22

Y1 - 2005/4/22

N2 - A DNA vaccine was tested in infant Rhesus macaques to evaluate its safety, immunogenicity and protective efficacy. Monkeys were vaccinated and challenged with a clinical isolate of human RSV. Vaccinated animals developed humoral and cellular responses following inoculation with plasmid DNA encoding the fusion (F) and nucleoprotein (N), from closely related bovine RSV. Vaccinated monkeys had decreased RSV in their lungs post-infection, and there was a qualitative difference in histopathology observed between vaccinated and unvaccinated animals. The combined result of safety and immunogenicity in a neonatal primate model is encouraging, suggesting the feasibility of DNA vaccines against RSV in infants.

AB - A DNA vaccine was tested in infant Rhesus macaques to evaluate its safety, immunogenicity and protective efficacy. Monkeys were vaccinated and challenged with a clinical isolate of human RSV. Vaccinated animals developed humoral and cellular responses following inoculation with plasmid DNA encoding the fusion (F) and nucleoprotein (N), from closely related bovine RSV. Vaccinated monkeys had decreased RSV in their lungs post-infection, and there was a qualitative difference in histopathology observed between vaccinated and unvaccinated animals. The combined result of safety and immunogenicity in a neonatal primate model is encouraging, suggesting the feasibility of DNA vaccines against RSV in infants.

KW - DNA immunization

KW - Rhesus monkeys

KW - RSV

UR - http://www.scopus.com/inward/record.url?scp=15244352217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15244352217&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2004.10.046

DO - 10.1016/j.vaccine.2004.10.046

M3 - Article

VL - 23

SP - 2928

EP - 2942

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 22

ER -